Delivery Order SPE2DB24D2205-SPE2DB25FEGUF
- Not listed
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a contract value of $3,157.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 16, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,342.80 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lyrica 50 mg capsules (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,550.74 for 90 capsules of Lyrica 100 mg on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,054.09 to AmerisourceBergen Drug Corp for the supply of Lyrica 50 mg capsules (90-count units) under a firm fixed price contract. This non-set-aside delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lyrica 100 mg capsules (quantity: 90 units) with a ceiling value of $2,514.26. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract is scheduled for ultimate completion on...
- The Defense Logistics Agency awarded a delivery order valued at $8,127.48 to AmerisourceBergen Drug Corp for 90 capsules of Lyrica 100 mg on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The delivery order will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Lyrica 100mg (90-count units) with a ceiling value of $8,197.02. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,069.03 to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units) under a firm fixed-price contract type. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a contract ceiling value of $4,142.53. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGUFDelivery Order
The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This non-set-aside, competitively awarded contract employs firm fixed price terms with an ultimate completion date of August 27, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts predominantly with the Defense Logistics Agency. As a prime vendor, the company supplies a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Lyrica, a neurological treatment medication, exemplifies the company's role in fulfilling routine pharmaceutical procurement requirements for federal military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 8/26/25 |